OncoPep Receives $2,525,000 New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    520 Boston Street North Andover, MA 01845
  • Company Description
    OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company’s proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.